News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Republic Services (NYSE:RSG) is pursuing aggressive M&A activity in 2026, with completed and planned …
Sharemaestro market context Price above Trend Line 52 weeks -18.6% · Next-week setup negative 29.3%AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have filed an amended Schedule 13G indicating a 5.02% passive ownership stake in Repay Holdings Corp (RPAY). This stake amounts to 4,499,761 shares of Class A Common Stock, which includes 768 shares …
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5,329,691 shares, or 5.05%, of Sarepta Therapeutics, Inc. common stock as of June 30, 2026. This reported amount includes 1,004,002 shares represented by Convertible Notes. Both entities share …
SueWallSt is reminding shareholders of Replimune Group, Inc. (REPL) about a lead plaintiff deadline of October 5, 2026, in a securities class action lawsuit. The lawsuit alleges that Replimune made misleading statements regarding the FDA's review of its RP1 resubmission, leading to an 84% …
Replimune Group Inc. (NASDAQ:REPL) saw a significant increase in short interest during July, rising 57.95% to 5.25 million shares. This represents 14.7% of the company's shares outstanding, indicating a growing bearish sentiment among investors. The average daily trading volume suggests it would take approximately …
Sarepta Therapeutics (SRPT) saw its flagship gene therapy, ELEVIDYS, experience a fifth consecutive quarterly revenue decline, with analysts from H.C. Wainwright & Co. reiterating a Sell rating and a $5.00 price target. Despite this, the market reaction was muted, suggesting investors are assigning significant …
Argus has raised its target price for Repligen Corporation (RGEN) to $173.00. Repligen, a global life sciences company, specializes in developing bioprocessing equipment and supplies for manufacturing biologic drugs. The current stock price for RGEN is $167.49.
Republic Services stock is holding steady in the low $210s, with a major long-term shareholder significantly increasing their stake by purchasing hundreds of thousands of shares. The company's latest quarterly results showed an earnings beat and higher fiscal 2026 EPS guidance, along with a …
Levi & Korsinsky, LLP has issued a shareholder alert regarding a securities class action lawsuit against Replimune Group, Inc. (NASDAQ: REPL). The lawsuit alleges that Replimune misled investors between October 20, 2025, and April 10, 2026, by claiming its RP1 FDA resubmission was on …
Replimune Group's CAO, Andrew Schwendenman, sold 7,632 shares of the company's stock for approximately $98,987 to cover tax-withholding obligations. Despite this insider sale, Replimune has seen positive analyst sentiment and recently priced a $150 million public offering for its oncology pipeline. However, the company …
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Republic Services stock sits at an interesting crossroads for valuation focused investors. Over the …
Sharemaestro market context Price above Trend Line 52 weeks -18.6% · Next-week setup negative 29.3%Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Senior Director of Investor Relations - Tamara Thornton Chief Executive Officer - Michael E. Severino President of R&D and Technical Operations - Dr. Louise Rodino-Klapac Chief Commercial Officer …
Sharemaestro market context Price below Trend Line 52 weeks -24.7% · Next-week setup negative 25.3%Konstantinos Xynos, an insider at Replimune Group (NASDAQ:REPL), sold 11,447 shares of the company's stock for approximately $148,468 to cover tax obligations. Despite the sale, Replimune's stock has performed strongly, nearing its 52-week high, although the company reported a larger-than-expected quarterly loss. Institutional ownership …
Replimune Group CEO Sushil Patel sold 39,341 shares of the company's common stock for $510,252 on August 10, 2026, to cover tax withholding obligations. This sale was not discretionary and was tied to performance-based restricted stock units. The company has recently received FDA accelerated …
Cascade Investment, L.L.C., a major shareholder in Republic Services (NYSE:RSG), recently acquired 261,664 shares of the company's stock for over $56 million. This transaction, along with other recent purchases, has increased their ownership in Republic Services. The company has also reported strong quarterly earnings, …
The article discusses the accelerated approval of Replimune Group Inc.'s biologic, RP1, by the FDA for advanced melanoma, following a 10:3 advisory committee vote. This approval comes after a protracted process involving two previous rejections, political pressure, and significant debate among experts about the …
Cascade Investment, L.L.C. and William H. Gates III, identified as 10% owners of Republic Services, Inc. (RSG), purchased a total of 501,664 shares of the company's common stock. These open-market transactions took place on August 10-11, 2026, across seven trades. The shares were acquired …
Robbins LLP is reminding investors of a class action lawsuit against Replimune Group, Inc. (NASDAQ: REPL). The lawsuit alleges that Replimune misled investors about the efficacy and viability of its lead product candidate RP1, after the FDA rejected its Biologics License Application due to …
Repay Holdings (RPAY) saw its stock slip despite reporting strong Q2 2026 revenue growth of 33% and narrowed losses. The company is generating cash and trading at a P/S ratio below sector averages, with adjusted EBITDA margins holding steady. However, concerns remain regarding its …
UBS has increased its price target on Intrepid Potash (IPI) from $26 to $29, while reiterating a Sell rating on the stock. This adjustment comes after the company's recent Q2 2026 earnings call and production results, reflecting an updated outlook from the analyst firm. …
Zacks Research upgraded Intrepid Potash (NYSE:IPI) from a "strong sell" to a "hold" rating. The company's stock opened at $36.97 and saw a 2.1% decrease, with institutional investors holding 56.13% of the shares. Despite missing EPS estimates, Intrepid Potash exceeded revenue expectations for the …
Republic Services Inc. (NYSE:RSG) recently released its second-quarter results, with shares gaining 3.6% to US$215. While revenues of US$4.4 billion met analyst predictions, the company surpassed expectations with a statutory profit of US$1.84 per share. Analysts have largely maintained their forecasts, with expected revenues …
Wasatch Advisors LP has significantly increased its stake in Repligen Corporation (NASDAQ:RGEN) by 27.9%, purchasing an additional 346,720 shares, bringing its total holdings to 1.59 million shares valued at approximately $217 million. This makes Repligen the 19th largest holding for Wasatch Advisors, representing 1.4% …
Assenagon Asset Management S.A. has acquired 70,995 new shares of Repligen Corporation (NASDAQ:RGEN) valued at approximately $9.7 million, making them a 0.13% owner of the biotechnology company. Repligen recently surpassed its quarterly earnings and revenue expectations, reporting $0.54 EPS against a $0.45 consensus, with …
Assenagon Asset Management S.A. has initiated a new $8.16 million investment in Sarepta Therapeutics (NASDAQ:SRPT), acquiring 454,375 shares, which represents approximately 0.43% of the company. Institutional investors and hedge funds collectively own about 86.68% of SRPT. Despite mixed analyst ratings, with a consensus "Hold" …
Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Replimune Group, Inc. (NASDAQ: REPL) for purchasers of securities between October 20, 2025, and April 10, 2026. The lawsuit alleges that Replimune made false and misleading statements regarding its Biologics License Application …
Republic Services' EVP Amanda Hodges had 124 Restricted Stock Units (RSUs) vest on August 9, 2026, which included accrued dividend equivalents from a 2024 grant. To cover tax obligations, 52 shares of common stock were withheld at a fair market value of $214.56 per …
Baker Bros. Advisors and related entities have filed an amended beneficial ownership report for Replimune Group, Inc. common stock, revealing a beneficial ownership of 11,075,336 shares, which represents an 11.8% stake. The report also details Baker Bros.' purchase of all 2,736,340 pre-funded warrants in …
Search by ticker symbol or company name and select a result to open its chart.